20.2% for Pradaxa ® 150 mg dual-therapy versus 25.7% for warfarin triple therapy, which translates into a 28% lower risk Both Pradaxa ® dual therapy groups also showed lower rates of major bleeding ...
Dabigatran has a similar effect on the recurrence of acute venous thromboembolism (VTE) and a lower bleeding risk compared with warfarin, according to a study published online December 26, 2013, ahead ...
Patients with atrial fibrillation (A-fib) or venous thromboembolism (VTE) who experience major bleeding on the direct thrombin inhibitor dabigatran require a shorter intensive care stay and show a ...
HealthDay News — In clinical practice, patients starting dabigatran therapy do not have significantly different rates of ischemic stroke or extracranial hemorrhage than those starting warfarin therapy ...
RIDGEFIELD, Conn., March 19, 2017 /PRNewswire/ -- Important new data from the RE-CIRCUIT® study show a better safety profile for Pradaxa® (dabigatran etexilate mesylate) compared to warfarin in atrial ...
(HealthDay News) — For patients with nonvalvular atrial fibrillation, dabigatran 150mg is comparable to warfarin for preventing ischemic stroke, and correlates with lower risk of intracranial bleeding ...
Pradaxa® (dabigatran etexilate mesylate) U.S. Label Now Affirms Superior Reduction in Ischemic and Hemorrhagic Stroke Versus Warfarin in Patients with Non-Valvular Atrial Fibrillation RIDGEFIELD, Conn ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The parallel, open-label GIRAF trial randomly assigned ...
The Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial compared the efficacy and safety of dabigatran (Pradax in Canada and Pradaxa in Europe), a new oral direct thrombin ...
Dr. Noel G. Boyle, Professor of Medicine, Ronald Reagan UCLA Medical Center, Los Angeles, talks about new medications that can work as alternatives to warfarin for atrial fibrillation patients who are ...
A study of Medicare beneficiaries suggests the anticoagulant medication dabigatran should be prescribed with caution because it appears to be associated with a higher incidence of major bleeding and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback